TY - JOUR
T1 - The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities
AU - Bonci, Désirée
AU - Coppola, Valeria
AU - Musumeci, Maria
AU - Addario, Antonio
AU - Giuffrida, Raffaella
AU - Memeo, Lorenzo
AU - D'Urso, Leonardo
AU - Pagliuca, Alfredo
AU - Biffoni, Mauro
AU - Labbaye, Catherine
AU - Bartucci, Monica
AU - Muto, Giovanni
AU - Peschle, Cesare
AU - De Maria, Ruggero
PY - 2008/11
Y1 - 2008/11
N2 - MicroRNAs (miRNAs) are noncoding small RNAs that repress protein translation by targeting specific messenger RNAs. miR-15a and miR-16-1 act as putative tumor suppressors by targeting the oncogene BCL2. These miRNAs form a cluster at the chromosomal region 13q14, which is frequently deleted in cancer. Here, we report that the miR-15a and miR-16-1 cluster targets CCND1 (encoding cyclin D1) and WNT3A, which promotes several tumorigenic features such as survival, proliferation and invasion. In cancer cells of advanced prostate tumors, the miR-15a and miR-16 level is significantly decreased, whereas the expression of BCL2, CCND1 and WNT3A is inversely upregulated. Delivery of antagomirs specific for miR-15a and miR-16 to normal mouse prostate results in marked hyperplasia, and knockdown of miR-15a and miR-16 promotes survival, proliferation and invasiveness of untransformed prostate cells, which become tumorigenic in immunodeficient NOD-SCID mice. Conversely, reconstitution of miR-15a and miR-16-1 expression results in growth arrest, apoptosis and marked regression of prostate tumor xenografts. Altogether, we propose that miR-15a and miR-16 act as tumor suppressor genes in prostate cancer through the control of cell survival, proliferation and invasion. These findings have therapeutic implications and may be exploited for future treatment of prostate cancer.
AB - MicroRNAs (miRNAs) are noncoding small RNAs that repress protein translation by targeting specific messenger RNAs. miR-15a and miR-16-1 act as putative tumor suppressors by targeting the oncogene BCL2. These miRNAs form a cluster at the chromosomal region 13q14, which is frequently deleted in cancer. Here, we report that the miR-15a and miR-16-1 cluster targets CCND1 (encoding cyclin D1) and WNT3A, which promotes several tumorigenic features such as survival, proliferation and invasion. In cancer cells of advanced prostate tumors, the miR-15a and miR-16 level is significantly decreased, whereas the expression of BCL2, CCND1 and WNT3A is inversely upregulated. Delivery of antagomirs specific for miR-15a and miR-16 to normal mouse prostate results in marked hyperplasia, and knockdown of miR-15a and miR-16 promotes survival, proliferation and invasiveness of untransformed prostate cells, which become tumorigenic in immunodeficient NOD-SCID mice. Conversely, reconstitution of miR-15a and miR-16-1 expression results in growth arrest, apoptosis and marked regression of prostate tumor xenografts. Altogether, we propose that miR-15a and miR-16 act as tumor suppressor genes in prostate cancer through the control of cell survival, proliferation and invasion. These findings have therapeutic implications and may be exploited for future treatment of prostate cancer.
UR - http://www.scopus.com/inward/record.url?scp=55549114664&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=55549114664&partnerID=8YFLogxK
U2 - 10.1038/nm.1880
DO - 10.1038/nm.1880
M3 - Article
C2 - 18931683
AN - SCOPUS:55549114664
VL - 14
SP - 1271
EP - 1277
JO - Nature Medicine
JF - Nature Medicine
SN - 1078-8956
IS - 11
ER -